Biotech Series B Investors & VC Firms

725 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Yonjin Venture LLC 2 people	Cambridge	US	Seed–Series B	—	+ Add to CRM
Malaysia Debt Ventures Bhd. 2 people	Kuala Lumpur	MY	Seed–Late Stage	—	+ Add to CRM
Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd. 2 people	Shenzhen	CN	Seed–Series B	—	+ Add to CRM
CDIB Capital	Hong Kong	HK	Series A–Series C	—	+ Add to CRM
IBK Capital	Seoul	KR	Seed–Series B	—	+ Add to CRM
Quark Venture Inc.	Vancouver	CA	Seed–Series C	—	+ Add to CRM
Woodford Investment Management	Oxford	GB	Series A–Growth	—	+ Add to CRM
Ippon 1 person	Geneva	CH	Series A–Growth	—	+ Add to CRM
RecapHealth Ventures 1 person	Vancouver	CA	Seed–Late Stage	—	+ Add to CRM
Shanghai STVC Group 1 person	Shanghai	CN	Seed–Growth	—	+ Add to CRM
HSBC Innovation Ventures 1 person	London	GB	Seed–Growth	—	+ Add to CRM
Ilshin Investment Co. Ltd. 1 person	Seoul	KR	Seed–Late Stage	—	+ Add to CRM
3H Health Investment	Shanghai	CN	Series A–Late Stage	—	+ Add to CRM
Providence Investment Company Limited	Germany	US	Seed–Growth	—	+ Add to CRM
Lake Bleu Capital	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
PTV Healthcare Capital	Singapore	SG	Series B	—	+ Add to CRM
Avlar BioVentures	Madingley	GB	Series A–Growth	—	+ Add to CRM
Hong Kong X Technology Fund	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
Candy Capital	—	GB	Seed–Growth	—	+ Add to CRM
Cdh Venture Management Company Limited	Hong Kong	HK	Series A–Series C	—	+ Add to CRM
China Development Industrial Bank (CDIB)	Taipei	TW	Series A–Series B	—	+ Add to CRM
EQT Fund Management S.à.r.l.	—	NL	Seed–Growth	—	+ Add to CRM
Fubon Financial Holdings	Taipei	TW	Series A–Series B	—	+ Add to CRM
Future Fund: Breakthrough	—	GB	Series B–Growth	—	+ Add to CRM